Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II–III breast cancer patients using CytoSorter(®) system: a retrospective study

PURPOSE: Circulating tumor cells (CTCs) are known to be associated with late recurrence and poor prognosis in breast cancer (BC). Different CTC enrichment platforms have different CTC cut-off values for poor prognosis. This study aimed to evaluate whether preoperative CTCs could be a prognostic fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Lidan, Fan, Wan-Hung, Luan, Yi, Wu, Meiqiong, Zhao, Wenhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Drugs and Devices
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088762/
https://www.ncbi.nlm.nih.gov/pubmed/33987029
http://dx.doi.org/10.7717/peerj.11366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088762/
https://www.ncbi.nlm.nih.gov/pubmed/33987029
http://dx.doi.org/10.7717/peerj.11366

Ejemplares similares